Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Dhanda DS"'
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S113-S113
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S110-S110
Publikováno v:
Clinical Pharmacology & Therapeutics; Nov2017, Vol. 102 Issue 5, p805-814, 10p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ailawadhi S; Mayo Clinic, Jacksonville, Florida, United States., Arnulf B; Saint-Louis University Hospital AP-HP, Paris France., paris, France., Patel KK; The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States., Cavo M; Seràgnoli Institute of Hematology; Bologna University School of Medicine, Bologna, Italy, Bologna, Italy., Nooka AK; Emory University Winship Cancer Institute, Atlanta, Georgia, United States., Manier S; CHU Lille, Lille, France., Callander NS; University of Wisconsin, Madison, Wisconsin, United States., Costa LJ; University of Alabama at Birmingham, Vestavia Hills, Alabama, United States., Vij R; Washington University School of Medicine, St Louis, Missouri, United States., Bahlis NJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Moreau P; Hematology, University Hospital Hôtel-Dieu, Nantes, France., Solomon SR; Northside Hospital Cancer Institute, Atlanta, Georgia, United States., Abrahamsen IW; Oslo University Hospital, Oslo, Norway., Baz RC; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States., Broijl A; Erasmus MC Cancer Institute, Rotterdam, Netherlands., Chen C; Princess Margaret Cancer Centre, Toronto., Canada., Jagannath S; Mt. Sinai Medical Center, New York, New York, United States., Raje N; Massachusetts General Hospital, Boston, Massachusetts, United States., Scheid C; University of Cologne, Cologne, Germany., Delforge M; University of Leuven, Leuven, Belgium., Benjamin R; King's College Hospital, London, United Kingdom., Pabst T; University Hospital, Inselspital, Bern, Switzerland., Iida S; Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Berdeja JG; Tennessee Oncology, nashville, Tennessee, United States., Giralt SA; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Truppel-Hartmann A; 2seventy bio, Cambridge, Massachusetts, United States., Chen Y; Bristol Myers Squibb, Princeton, New Jersey, United States., Zhong X; Bristol Myers Squibb, Princeton, New Jersey, United States., Wu F; Bristol Myers Squibb, Princeton, New Jersey, United States., Piasecki J; Bristol Myers Squibb, Princeton, New Jersey, United States., Eliason L; Bristol Myers Squibb, Princeton, New Jersey, United States., Dhanda DS; Bristol Myers Squibb, Princeton, New Jersey, United States., Felten J; Bristol Myers Squibb, Boudry, Switzerland., Caia A; Bristol Myers Squibb, Boudry, Switzerland., Cook M; Bristol Myers Squibb, Boudry, Switzerland., Popa-Mckiver M; Bristol-Myers Squibb, Lawrenceville, New Jersey, United States., Rodriguez-Otero P; Cancer Center Clínica Universidad de Navarra, Pamplona, Spain.
Publikováno v:
Blood [Blood] 2024 Aug 28. Date of Electronic Publication: 2024 Aug 28.
Autor:
Delforge M; University Hospital Leuven, Leuven, Belgium. Electronic address: michel.delforge@uzleuven.de., Otero PR; Clínica Universidad de Navarra, Pamplona, Spain., Shah N; UCSF Medical Center, San Francisco, CA, USA., Moshkovich O; ICON plc, San Francisco, CA, USA., Braverman J; Bristol Myers Squibb, Princeton, NJ, USA., Dhanda DS; Bristol Myers Squibb, Princeton, NJ, USA., Lanar S; ICON plc, Lyon, France., Devlen J; ICON plc, Gaithersburg, MD, USA., Miera M; ICON plc, Gaithersburg, MD, USA., Gerould H; ICON plc, Gaithersburg, MD, USA., Campbell TB; Bristol Myers Squibb, Princeton, NJ, USA., Munshi NC; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, and Boston VA Healthcare System, Harvard Medical School, Boston, MA, USA.
Publikováno v:
Leukemia research [Leuk Res] 2023 Jun; Vol. 129, pp. 107074. Date of Electronic Publication: 2023 Apr 03.
Autor:
Shah N; University of California San Francisco, San Francisco, CA, USA. Electronic address: Nina.Shah@ucsf.edu., Delforge M; University Hospital Leuven, Leuven, Belgium., San-Miguel J; Clínica Universidad de Navarra, CCUN, CIMA, CIBERONC, IDISNA, Pamplona, Spain., Moshkovich O; ICON, Gaithersburg, MD, USA., Braverman J; Bristol Myers Squibb, Princeton, NJ, USA., Dhanda DS; Bristol Myers Squibb, Princeton, NJ, USA., Lanar S; ICON plc, Lyon, France., Miera M; ICON, Gaithersburg, MD, USA., Williams A; ICON plc, London, UK., Murphy R; ICON, Gaithersburg, MD, USA., Devlen J; ICON, Gaithersburg, MD, USA., Hege K; Bristol Myers Squibb, San Francisco, CA, USA., Campbell TB; Bristol Myers Squibb, Princeton, NJ, USA., Munshi NC; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Publikováno v:
Leukemia research [Leuk Res] 2022 Sep; Vol. 120, pp. 106921. Date of Electronic Publication: 2022 Jul 21.
Autor:
Delforge M; University Hospital Leuven, Leuven, Belgium., Shah N; University of California San Francisco, San Francisco, CA., Miguel JSF; Clínica Universidad de Navarra, Navarra, Spain., Braverman J; Bristol Myers Squibb, Princeton, NJ., Dhanda DS; Bristol Myers Squibb, Princeton, NJ., Shi L; Evidera, Waltham, MA; and., Guo S; Evidera, Waltham, MA; and., Yu P; Evidera, Waltham, MA; and., Liao W; Evidera, Waltham, MA; and., Campbell TB; Bristol Myers Squibb, Princeton, NJ., Munshi NC; The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2022 Feb 22; Vol. 6 (4), pp. 1309-1318.
Autor:
Dhanasiri S; Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland. Electronic address: sujith.dhanasiri@bms.com., Hollier-Hann G; Genesis Research, Newcastle, United Kingdom., Stothard C; Genesis Research, Newcastle, United Kingdom., Dhanda DS; Bristol Myers Squibb, Princeton, New Jersey, USA., Davies FE; NYU Langone Health, New York, New York, USA., Rodriguez-Otero P; Clinica Universidad de Navarra, Navarra, Spain.
Publikováno v:
Clinical therapeutics [Clin Ther] 2021 Nov; Vol. 43 (11), pp. 1983-1996.e3. Date of Electronic Publication: 2021 Nov 02.